what glp-1 does noom use Our Weight Loss Journey Noom Enters Longevity Health Space
Description
Its about giving patients another evidence-based option
[DOI] [PubMed] [Google Scholar] 70.Kooijman S., Wang Y., Parlevliet E.T., Boon M.R., Edelschaap D., Snaterse G., et al
Key molecules in this space include semaglutide, liraglutide, dulaglutide, and orlistat, developed by companies like Novo Nordisk, Eli Lilly, and Roche
In whats known as the SELECT trial, co-authored by UT Southwestern endocrinologist Ildiko Lingvay, M.D., M.P.H., M.S.C.S., 44% of patients using semaglutide lost more than 10% of their body weight within two years, and 11% of patients lost more than 20% more than enough to improve fertility
Additionally, retail pharmacies often provide counseling support, insurance processing, and promotional discounts, which further drive adoption and sustained use of GLP-1 therapies
